Form 4: GAN Limited Executive Giuseppe Gardali Reports Share Transactions
SEC Form 4 Filing
Giuseppe Gardali, President of B2B at GAN Limited, reports the acquisition and disposal of ordinary shares related to the settlement of Restricted Stock Units (RSUs).
Summary
- On March 11, 2025, Giuseppe Gardali, President of B2B at GAN Limited, reported transactions involving GAN Limited ordinary shares.
- Gardali acquired 6,032 shares through the settlement of Restricted Stock Units (RSUs).
- He also disposed of 2,836 shares to cover tax withholdings at a price of $1.78 per share.
- Following these transactions, Gardali directly owns 62,321 ordinary shares and 6,031 derivative securities (RSUs).
Sentiment
Score: 6
Explanation: The sentiment is neutral as the filing reflects routine transactions related to executive compensation. There are no indications of unusual activity or concerns.
Positives
- The vesting of RSUs indicates a continued alignment of the executive's interests with the company's performance.
Negatives
- The disposal of shares to cover tax obligations, while standard, slightly reduces the executive's holdings.
Future Outlook
The remaining RSUs will vest on March 11, 2026, potentially leading to further share transactions at that time.
Industry Context
Form 4 filings are a routine part of regulatory compliance for publicly traded companies, providing transparency into the transactions of company insiders. This filing indicates standard compensation practices through RSUs.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they are part of standard executive compensation practices.
Key Dates
| Date | Description |
|---|---|
| 03/11/2022 | Original grant date of the Restricted Stock Units (RSUs) |
| 03/11/2023 | First vesting date of the RSUs (one-fourth of the shares) |
| 03/11/2024 | Second vesting date of the RSUs (one-fourth of the shares) |
| 03/11/2025 | Date of reported transactions: RSU settlement and tax withholding. |
| 03/11/2026 | Final vesting date of the RSUs (remaining shares) |
| 03/12/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.